Screener
Acadia Pharmaceuticals ACAD Inventory For Long Term Contracts Or Programs
Inventory For Long Term Contracts Or Programs at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryForLongTermContractsOrPrograms.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Operating lease right-of-use assets | 69,424 | 47,354 |
| Intangible assets, net | 103,448 | 108,893 |
| Restricted cash | 7,846 | 7,845 |
| Long-term inventory | 76,301 | 76,704 |
| Deferred tax assets | 240,679 | 249,879 |
| Other assets | 3,550 | 3,896 |
| Total assets | $1,742,900 | $1,564,195 |
| Liabilities and stockholders’ equity |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's inventory for long term contracts or programs?
- Acadia Pharmaceuticals (ACAD) reported inventory for long term contracts or programs of $76.3M in Q2 2026.
- How has Acadia Pharmaceuticals's inventory for long term contracts or programs changed year-over-year?
- Acadia Pharmaceuticals's inventory for long term contracts or programs decreased by 9.6% year-over-year, from $84.4M to $76.3M.
- What is the long-term trend for Acadia Pharmaceuticals's inventory for long term contracts or programs?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's inventory for long term contracts or programs has grown at a 87.4% compound annual growth rate (CAGR), from $6.22M to $76.7M.
- What does inventory for long term contracts or programs mean?
- Inventory For Long Term Contracts Or Programs
Ask your AI about Acadia Pharmaceuticals's inventory for long term contracts or programs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude